Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers

Abstract Background Cerebrospinal fluid (CSF) lactate levels have been suggested to be associated with disease severity and progression in several neurological diseases as an indicator of impaired energy metabolism, neuronal death, or microglial activation. Few studies have examined CSF lactate leve...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Paul Theo Zebhauser, Achim Berthele, Oliver Goldhardt, Janine Diehl-Schmid, Josef Priller, Marion Ortner, Timo Grimmer
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2022-04-01
Rangatū:	Alzheimer’s Research & Therapy
Ngā marau:	Alzheimer’s disease Cerebrospinal fluid Lactate Biomarkers Blood-brain barrier
Urunga tuihono:	https://doi.org/10.1186/s13195-022-01004-9
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!